EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma

被引:0
|
作者
Alexander J. J. Smits
J. Alain Kummer
John W. J. Hinrichs
Gerarda J. M. Herder
Karen C. Scheidel-Jacobse
N. Mehdi Jiwa
T. Emiel G. Ruijter
Peet T. G. A. Nooijen
Monica G. Looijen-Salamon
Marjolijn J. L. Ligtenberg
Frederik B. Thunnissen
Daniëlle A. M. Heideman
Roel A. de Weger
Aryan Vink
机构
[1] St. Antonius Hospital,Department of Pathology
[2] University Medical Center Utrecht,Department of Pathology
[3] St. Antonius Hospital,Department of Pulmonary Diseases
[4] Medical Center Alkmaar,Department of Pathology
[5] Rijnstate Hospital,Department of Pathology
[6] Jeroen Bosch Hospital,Department of Pathology
[7] Radboud University Nijmegen Medical Centre,Department of Pathology
[8] VU University Medical Center,Department of Pathology
来源
Cellular Oncology | 2012年 / 35卷
关键词
Non-small cell lung cancer; Adenocarcinoma; Metastasis; Pleural effusion;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:189 / 196
页数:7
相关论文
共 50 条
  • [41] EGFR and KRAS Mutations in Lung Carcinoma Molecular Testing by Using Cytology Specimens
    Billah, Shahreen
    Stewart, John
    Staerkel, Gregg
    Chen, Su
    Gong, Yun
    Guo, Ming
    CANCER CYTOPATHOLOGY, 2011, 119 (02) : 111 - 117
  • [42] Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples
    Yao, Yi
    Peng, Min
    Shen, Qinglin
    Hu, Qinyong
    Gong, Hongyun
    Li, Qingqing
    Zheng, Zhongliang
    Xu, Bin
    Li, Yingge
    Dong, Yi
    THORACIC CANCER, 2019, 10 (02) : 193 - 202
  • [43] Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations
    Schwalk, Audra J.
    Ost, David E.
    Saltijeral, Sahara N.
    De La Garza, Henriette
    Casal, Roberto F.
    Jimenez, Carlos A.
    Eapen, Georgie A.
    Lewis, Jeff
    Rinsurongkawong, Waree
    Rinsurongkawong, Vadeerat
    Lee, Jack
    Elamin, Yasir
    Zhang, Jianjun
    Roth, Jack A.
    Swisher, Stephen
    Heymach, John, V
    Grosu, Horiana B.
    CHEST, 2021, 159 (03) : 1256 - 1264
  • [44] Frequency of EGFR Mutations in NSCLC Patients of the Lung Center of the Philippines
    Barzaga, Maria Teresa A.
    Heralde, Francisco Iii M.
    Danguilan, Jose Luis J.
    Tan-Liu, Nelia S.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S590 - S590
  • [45] Anterior gradient 2 is correlated with EGFR mutation in lung adenocarcinoma tissues
    Narumi, Sodai
    Miki, Yasuhiro
    Hata, Shuko
    Ebina, Masahito
    Saito, Mikiyoshi
    Mori, Kazushige
    Kobayashi, Makoto
    Suzuki, Takashi
    Iwabuchi, Erina
    Sato, Ikuro
    Maemondo, Makoto
    Endo, Chiaki
    Inoue, Akira
    Kondo, Takashi
    Yamada-Okabe, Hisafumi
    Ichinose, Masakazu
    Sasano, Hironobu
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (02) : E234 - E242
  • [46] RELEVANCE BETWEEN CEA LEVEL AND EGFR MUTATION, EFFICACY OF EGFR-TKI IN PATIENTS WITH LUNG ADENOCARCINOMA
    Zhang, Wei Y.
    Han, Hui B.
    Jin, Bo
    Shao, Hua M.
    Dong, Yu
    Huang, Mi A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S891 - S891
  • [47] Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinoma
    Nishii, Teppei
    Yokose, Tomoyuki
    Miyagi, Yohei
    Daigo, Yataro
    Isaka, Tetsuya
    Furumoto, Hideyuki
    Ito, Hiroyuki
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Oshita, Fumihiro
    Yamada, Kouzo
    Matsukuma, Shoichi
    Nakayama, Haruhiko
    Masuda, Munetaka
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E204 - E211
  • [48] Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma
    Tomonaga, Nanae
    Nakamura, Yoichi
    Yamaguchi, Hiroyuki
    Ikeda, Takaya
    Mizoguchi, Kosuke
    Motoshima, Kohei
    Doi, Seiji
    Nakatomi, Katsumi
    Iida, Tetsuya
    Hayashi, Tomayoshi
    Nagayasu, Takeshi
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    CLINICAL LUNG CANCER, 2013, 14 (05) : 521 - 526
  • [49] EGFR activating mutation in lung adenocarcinoma: Risk factor of thromboembolic event?
    Noel-Savina, E.
    Paleiron, N.
    Le Gal, G.
    Descourt, R.
    REVUE DES MALADIES RESPIRATOIRES, 2012, 29 (09) : 1137 - 1140
  • [50] EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma
    Toki, Maria I.
    Carvajal-Hausdorf, Daniel E.
    Altan, Mehmet
    McLaughlin, Joseph
    Henick, Brian
    Schalper, Kurt A.
    Syrigos, Konstantinos N.
    Rimm, David L.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : 1901 - 1911